Page last updated: 2024-08-21

fluorobenzenes and Brain Emboli

fluorobenzenes has been researched along with Brain Emboli in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akasaka, M; Kaneko, K; Kiribayashi, N; Kubota, I; Niizeki, T; Omi, K; Saito, H; Sasaki, T; Sugawara, S; Takahashi, T	1
Balbarini, A; Conte, L; Cortese, B; De Carlo, M; Misuraca, L; Pennesi, M; Petronio, AS; Pitì, A	1

Trials

1 trial(s) available for fluorobenzenes and Brain Emboli

Article	Year
Design of the rosuvastatin pretreatment to reduce embolization during Carotid Artery Stenting trial. Journal of cardiovascular medicine (Hagerstown, Md.), 2014, Volume: 15, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; Carotid Artery, Common; Carotid Stenosis; Dose-Response Relationship, Drug; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Embolism; Male; Middle Aged; Preoperative Care; Prospective Studies; Prosthesis Design; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Stents; Sulfonamides; Treatment Outcome; Young Adult	2014

Article

Year

Design of the rosuvastatin pretreatment to reduce embolization during Carotid Artery Stenting trial.

Journal of cardiovascular medicine (Hagerstown, Md.), 2014, Volume: 15, Issue:7

Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; Carotid Artery, Common; Carotid Stenosis; Dose-Response Relationship, Drug; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Embolism; Male; Middle Aged; Preoperative Care; Prospective Studies; Prosthesis Design; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Stents; Sulfonamides; Treatment Outcome; Young Adult

2014

Other Studies

1 other study(ies) available for fluorobenzenes and Brain Emboli

Article	Year
Rosuvastatin improves plaque morphology in cerebral embolism patients with normal low-density lipoprotein and severe aortic arch plaque. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014, Volume: 23, Issue:6 Topics: Aged; Aorta, Thoracic; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Embolism; Lipids; Lipoproteins, LDL; Male; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2014

Article

Year

Rosuvastatin improves plaque morphology in cerebral embolism patients with normal low-density lipoprotein and severe aortic arch plaque.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014, Volume: 23, Issue:6

Topics: Aged; Aorta, Thoracic; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Embolism; Lipids; Lipoproteins, LDL; Male; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome

2014